NCT01493726 A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia Status COMPLETED Phase PHASE1
NCT01493622 The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia Status COMPLETED Phase PHASE4
NCT01491490 Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine Status TERMINATED Phase PHASE2
NCT01491412 Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia Status COMPLETED Phase N/A
NCT01490567 A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia Status UNKNOWN Phase PHASE4
NCT01488929 Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia Status COMPLETED Phase PHASE2
NCT01487668 Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders Status COMPLETED Phase NA
NCT01481883 Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men? Status COMPLETED Phase PHASE4
NCT01479413 Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs Status COMPLETED Phase N/A
NCT01479400 Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study Status COMPLETED Phase N/A
NCT01477918 Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea Status UNKNOWN Phase N/A
NCT01474395 N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia Status UNKNOWN Phase PHASE2
NCT01469039 A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia Status COMPLETED Phase PHASE3
NCT01466439 Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component Status COMPLETED Phase PHASE2
NCT01465074 Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia Status TERMINATED Phase NA
NCT01459029 High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia Status UNKNOWN Phase PHASE2
NCT01457339 Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia Status COMPLETED Phase PHASE1
NCT01456897 A Long-term Trial of OPC-34712 in Patients With Schizophrenia Status COMPLETED Phase PHASE3